Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Andrew Spencer, MBChB, FRACP, PhD
Principal Investigator
The Alfred
Australia: Department of Health and Ageing Therapeutic Goods Administration
7/04
NCT00164086
Name | Location |
---|